/Investor DB

Nextech Invest — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Flareflare.runJul 2026 · $85M

Flare develops AI-driven systems to manage essential workers—such as drivers, cleaners, security guards, and domestic workers—in emerging markets, vertically integrating its technology platform, worker staffing (via subsidiary Drive-Z), and customer implementation.

AI & Machine LearningFuture of WorkHR TechTokyo, JP

Kazuki Kamiya(CEO)Satoru Ichihara(COO)Shinya Hayashi(CSO)Hidefumi Iwaki(CFO)Tomohiro Sasaki(Executive Officer (Product Development))

Co-investorsANOBAKACARTA VENTURES, Inc.Spiral VenturesAgent CapitalCasdin CapitalInvus+2 more

Flaregetflare.co.ukinJul 2026 · $85M

Flare is a Shopify app that calculates location-specific delivery dates, methods, cut-off times and rates at checkout based on a customer's exact postcode or ZIP code, down to individual zones.

E-commerceLogistics & Supply ChainRetail TechSaaSLondon, GB

Daniel Parekh-Hill(CEO)inAlex Hooper(CTO)in

Co-investorsEntrepreneur FirstAgent CapitalBase10 PartnersCasdin CapitalInovia CapitalInvus+3 more

Pharmapharma.hrinSep 2026

The Faculty of Pharmacy and Biochemistry offers pharmacy and biochemistry degree programs, including a Pharmacy programme in English aligned with EU Directive 2005/36/EC for EU/EEA registration.

EdTech

Co-investorsVesna AdvisorsRA CapitalThe Column Group

Stipple Biostipple.bioin𝕏Series A · Apr 2026 · $100M

Stipple Bio develops targeted oncology therapies that act on tumor-specific cell surface epitopes to expand druggable targets and improve therapeutic index for cancer patients.

BiotechHealthtechCambridge, US

Aaron Ring(Co-founder)inAashish Manglik(Co-founder)inJeff Landau(Chief Executive Officer)inRoland Gendron(Chief Business Officer)inMichelle Zhang(Chief Scientific Officer)in

BoardVineeta Agarwala(Director)in

Co-investorsRA CapitalAndreessen HorowitzGV (Google Ventures)Magnetic VenturesOMX VenturesAxial VC+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.